Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly referred to a specialist with a suspected or confirmed diagnosis of liver cancer (hepatocellular carcinoma, or HCC)
- People who are 18 years of age or older
Who may not be able to join:
- People who do not wish to take part in the study
- People whom the responsible doctor determines are not suitable to undergo a PET scan
- People whose treatment plan involves systemic chemotherapy (cancer-fighting drugs given through the whole body) or comfort-focused care only (best supportive care)
- People with significantly reduced kidney function (confirm with trial site for specific measurement details)
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +4527491598
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity and specificity of the PET tracer 18F-FDGal; Metabolic function of the liver evaluated by the PET tracer 18F-FDGal
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.